Skip to main navigation Skip to search Skip to main content

CD30+ Primary Cutaneous Anaplastic Large Cell Lymphoma

  • Amrita Goyal
  • , Joi B. Carter
  • , Jeffrey A. Barnes
  • , Nicole R. Leboeuf
  • , Lyn Mcdivitt Duncan

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Primary cutaneous anaplastic large cell lymphoma (pcALCL), a member of the spectrum of CD30+ lymphoproliferative diseases, has an excellent prognosis. This indolent lymphoma is the second most common of all cutaneous T-cell lymphomas. It typically presents with solitary cutaneous and subcutaneous erythematous-to-violaceous papules and nodules. Although relapse after treatment is very common, patients are typically asymptomatic, and the vast majority do not experience extracutaneous spread.

Original languageEnglish (US)
Title of host publicationAtlas of Cutaneous Lymphomas
Subtitle of host publicationClassification and Differential Diagnosis
PublisherSpringer International Publishing
Pages103-108
Number of pages6
ISBN (Electronic)9783319172170
ISBN (Print)9783319172163
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

Keywords

  • Adult T-cell leukemia/lymphoma (ALCL)
  • CD30
  • CD30+ large cell transformation
  • CD30+ lymphoproliferative disease
  • CD4+
  • Lymphomatoid papulosis
  • Mycosis fungoides
  • Primary cutaneous anaplastic large cell lymphoma
  • Systemic anaplastic large cell lymphoma

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'CD30+ Primary Cutaneous Anaplastic Large Cell Lymphoma'. Together they form a unique fingerprint.

Cite this